Table 1.

Data from a series of patients with severe morning SI treated with nightly bedtime sustained-release stimulant medication

	Values
Sex, % female	63.6
Age, mean (SD) [range], years	33 (14.1) [17–50]
Major adverse consequences from SI, n
Work	12
School	4
Interpersonal	3
Child care	2
Personal medical care responsibilities	1
Associated sleep disorders, % (n/total n)	40.9 (9/22)
OSA, n	3
Narcolepsy, n	3
DSPS, n	2
NREM parasomnia, n	2
PLMD, n	1
Multiple, n	1
Associated psychiatric disorders, % (n/total n)	68.2 (15/22)
SI treatment, substantial/full sustained response, % (n/total n)	86.4 (19/22)
Treatment follow-up, mean (SD) [range], years	2.7 (2.6) [0.5–10]

n = 22. Data from reference 7. DSPS = delayed sleep-phase syndrome; NREM = non–rapid eye movement; OSA = obstructive sleep apnea; PLMD = periodic limb movement disorder; SD = standard deviation; SI = sleep inertia.